Pharmafile Logo

Laminar Medica Ltd

Laminar Medica specialises in the design, test, manufacture and qualification of insulated shipping systems, used by the pharmaceutical and biotech industries globally. These systems protect vaccines, drugs, blood and associated medical products from extremes of temperature during transportation.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

No items found

Company Details

Unit 4, Tring Industrial Estate Icknield Way, Tring, Hertfordshire, HP23 4JX, United Kingdom
+44 (0)1442 828664

 Latest Content from PMHub 

Working with, Advocating for, and Empowering Patients

A holistic view of how to work with patients virtually

The concordance conundrum: the value of improving patient experience

This is the first in a series of articles where we explore how the current climate presents companies with a multitude of opportunities to improve communication between healthcare organisations and...

Porterhouse welcomes additional expertise to its creative team

Porterhouse Medical Group is delighted to welcome Jenny Barrett into our growing creative team as a Senior Designer.Jenny has over 35 years of experience as a creative, having worked in...

Demand Diversity Podcast

The unacceptable lack of diversity among clinical research participants would suggest that we are.As we begin our campaign to demand diversity in the clinical research space, we invite you to...

ACCOMPLISH MEANINGFUL HCP ENGAGEMENT ONLINE

The art of delivering valuable customer journeys aligned to your key messages in 2020

Lucid Group are shortlisted in three categories for Communiqué 2020

Lucid’s talent for creating industry-leading programmes is clear to see as they celebrate three of its campaigns being shortlisted for Communiqué 2020, as well as making the finals forThe Real...

Bedrock double up

Bedrock selected as a finalist in two categories for 2020 Communiqué awards

OPEN Health use PR to support clinical trial recruitment

International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2

Covid-19: what could it mean for the diabetic population?

Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it